skip to main content

GLP-1 pancreatitis symptoms — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardEndocrine TherapeuticsGLP-1 pancreatitis symptomsGPhC CRA

A patient recently started semaglutide and reports severe persistent upper abdominal pain radiating to the back with vomiting. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Advise urgent medical assessment and withhold further dose pending review

Severe persistent abdominal pain on GLP-1 receptor agonist therapy may indicate pancreatitis. This makes advise urgent medical assessment and withhold further dose pending review the single best answer in this scenario. The other options would either miss the key safety issue, delay appropriate review, or fail to meet the relevant clinical or professional requirement.

Reference: BNF; MHRA